US20180289299A1 - Microfluidic Systems For Electrochemical Transdermal Analyte Sensing Using a Capillary-Located Electrode - Google Patents
Microfluidic Systems For Electrochemical Transdermal Analyte Sensing Using a Capillary-Located Electrode Download PDFInfo
- Publication number
- US20180289299A1 US20180289299A1 US16/005,826 US201816005826A US2018289299A1 US 20180289299 A1 US20180289299 A1 US 20180289299A1 US 201816005826 A US201816005826 A US 201816005826A US 2018289299 A1 US2018289299 A1 US 2018289299A1
- Authority
- US
- United States
- Prior art keywords
- layer
- metal electrode
- electrode layer
- capillary channel
- sensing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 21
- 229910052751 metal Inorganic materials 0.000 claims abstract description 28
- 239000002184 metal Substances 0.000 claims abstract description 28
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 19
- 210000003722 extracellular fluid Anatomy 0.000 claims abstract description 17
- 238000012544 monitoring process Methods 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims description 20
- 229920000128 polypyrrole Polymers 0.000 claims description 18
- 108010015776 Glucose oxidase Proteins 0.000 claims description 17
- 210000003491 skin Anatomy 0.000 claims description 17
- 239000004366 Glucose oxidase Substances 0.000 claims description 15
- 229940116332 glucose oxidase Drugs 0.000 claims description 15
- 235000019420 glucose oxidase Nutrition 0.000 claims description 15
- 238000001514 detection method Methods 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 8
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical group [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052737 gold Inorganic materials 0.000 claims description 7
- 239000010931 gold Substances 0.000 claims description 7
- 239000002322 conducting polymer Substances 0.000 claims description 6
- 229920001940 conductive polymer Polymers 0.000 claims description 6
- 239000011521 glass Substances 0.000 claims description 6
- 229920001296 polysiloxane Polymers 0.000 claims description 5
- 229910052697 platinum Inorganic materials 0.000 claims description 4
- 210000000434 stratum corneum Anatomy 0.000 claims description 4
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical group [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 claims description 3
- 230000009977 dual effect Effects 0.000 claims 3
- 238000012806 monitoring device Methods 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 14
- 239000008103 glucose Substances 0.000 abstract description 14
- 239000011540 sensing material Substances 0.000 description 12
- 230000002745 absorbent Effects 0.000 description 4
- 239000002250 absorbent Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002679 ablation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000004070 electrodeposition Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002706 hydrostatic effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003131 biological toxin Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 238000000970 chrono-amperometry Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000000835 electrochemical detection Methods 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical class [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000001465 metallisation Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 125000001484 phenothiazinyl group Chemical class C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- 125000001644 phenoxazinyl group Chemical class C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
- A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
- A61B5/14514—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1477—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means non-invasive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1491—Heated applicators
Definitions
- the present embodiments relate generally to non-invasive or minimally invasive transdermal measurement systems. More specifically, the embodiments relate to microfluidic transdermal glucose measurement systems in which a thin electrode is contained within a fluid-transmitted capillary, and processes for their production and use.
- Minimally invasive transdermal systems are described in, for example, co-owned U.S. Pat. Nos. 6,887,202 and 7,931,592, both entitled “Systems and Methods for Monitoring Health and Delivering Drugs Transdermally,” as well as co-owned U.S. application Ser. No. 13/459,392, each of which is incorporated herein by reference in its entirety. These systems, like the embodiments described herein, provide for a minimally invasive sampling technique and device suitable for rapid, inexpensive, unobtrusive, and pain-free monitoring of important biomedical markers, such as glucose.
- biomedical markers such as glucose
- a sensing device designed to be used in contact with the skin.
- the device contains a plurality of individually controllable sites for electrochemically monitoring an analyte, such as glucose, in interstitial fluid of a user.
- the device includes:
- hydrophobic layer designed to contact the skin
- overlaying first structural layer
- a capillary channel traversing these layers, thus providing an opening adjacent the skin
- said metal electrode layer is discontinuous at the circumference of said capillary channel, such that two non-contiguous edge portions of electrode are present within the circumference of said channel;
- an electronic element effective to produce heat when a sufficient voltage is applied thereto.
- the hydrophobic layer is hydrophobic silicone.
- the first structural layer may be a glass or ceramic-like material.
- the metal electrode layer is preferably gold or platinum, and the sensing layer, for use in detecting glucose, is preferably a conducting polymer, such as polypyrrole (PPy), modified with glucose oxidase (GOx), and preferably further containing an effective amount of a mediator such as ferricyanide.
- the second structural layer is preferably non-absorbent and/or hydrophobic, and may also be a layer of hydrophobic silicone.
- the diameter of the capillary channel in one embodiment, is about 50 ⁇ m.
- the thickness of the metal electrode layer is generally in the range of 100 nm to 1 micron range, e.g. 100-500 nm, 500-1000 nm, 500-800 nm, 250-750 nm, 300-500 nm, etc.
- An exemplary thickness is about 500 nm.
- the structural layers generally have thicknesses such that the overall thickness of the device is about 1 mm or less.
- the thickness of the applied sensing layer measured in a direction perpendicular to the capillary channel length, may be 200 nm or less, 100 nm or less, or 50 nm or less, in selected embodiments.
- a voltage is applied to the microheater sufficient to ablate the stratum corneum of the underlying skin, e.g. a voltage of about 3 V, typically for about 30 msec. This ablation allows interstitial fluid to enter the capillary channel, where it rises via both capillary action and the body's hydrostatic pressure and contacts the sensing material (e.g. PPy/GOx) within the capillary.
- a second voltage typically 0.2-0.4 V, is applied to the electrode layer, i.e. between the two above-described edge portions of the electrode layer, and the level of analyte (e.g. glucose) contacting the sensing material is electrochemically detected, in accordance with known methods.
- FIG. 1 illustrates an embodiment of a sensing device as disclosed herein.
- FIG. 1 A section of an exemplary sensing device, designed to be used in contact with the skin, is shown in FIG. 1 .
- the device typically contains a plurality of individually controllable sites, of which one is illustrated in the FIGURE, for electrochemically monitoring an analyte, such as glucose, in interstitial fluid of a user.
- the device in a preferred embodiment, includes:
- a hydrophobic layer 12 designed to contact the skin
- a capillary channel 20 traversing these layers, thus providing an opening adjacent the skin
- said metal electrode layer is discontinuous at the circumference of said capillary channel, such that two non-contiguous edge portions of electrode are present within the circumference of said channel;
- a sensing layer 22 effective to measure said analyte
- an electronic element (microheater) 24 surrounding the lower end of said capillary channel, adjacent to said hydrophobic layer, an electronic element (microheater) 24 , effective to produce heat when a sufficient voltage is applied thereto.
- the diameter of the capillary channel in one embodiment, is about 50 ⁇ m.
- the thickness of the metal electrode layer is generally in the range of 100 nm to 1 micron range, e.g. 100-500 nm, 500-1000 nm, 500-800 nm, 250-750 nm, 300-500 nm, etc.
- An exemplary thickness is about 500 nm.
- the thickness of the structural layers is not generally critical (although layer 12 should be sufficiently thick to insulate sensing material 22 from heat produced by microheater 24 ), but these may also be in the general range of hundreds of nm, e.g. 100-500 nm, 500-1000 nm, 500-800 nm, 250-750 nm, 300-500 nm, etc.
- the overall thickness of the device is generally less than 1 mm.
- the diameter of the capillary channel 20 in one embodiment, is about 50 ⁇ m. Other diameter ranges, e.g. 10-100 ⁇ m, or 25-75 ⁇ m, could also be effective.
- electrical conduits and contacts such that a voltage can be applied to the microheater, and an additional voltage can be applied to the electrode layer (i.e. between the two above-described edge portions of the electrode layer), and an electrochemical response from the sensing material/electrode layer, indicative of the concentration of analyte in the sample fluid, can be detected.
- the multiple detection sites within a device are preferably individually controllable; i.e. voltages can be selectively applied to a given detection site or sites by a user of the device.
- the hydrophobic layer 12 is hydrophobic silicone, though any biocompatible/non-irritating hydrophobic material can be used.
- the structural layer 14 may be a glass or ceramic-like material, which provides thermal insulation between the microheater 24 and sensing material 22 , or other structurally stable, nonabsorbent, preferably thermally insulating material.
- the metal electrode layer 16 is preferably gold or platinum.
- a sensing layer 22 effective to measure the analyte is present on one of the above-described edge portions of the metal electrode layer, such that it the sensing material is exposed to the interior of the capillary channel.
- the sensing layer 22 for use in detecting glucose, is preferably a conducting polymer, such as polypyrrole (PPy), modified with the enzyme glucose oxidase (GOx).
- the PPy-GOx layer is electrodeposited, in accordance with known methods (see, e.g., Liu et al., Matl. Sci. Eng. C 27(1):47-60 (January 2007); Yamada, et al., Chem. Lett. 26(3):201-202 (1997); Fortier, et al., Biosens. Bioelectronics 5:473-490 (1990)) as an extremely thin layer on an exposed face of the metal electrode, as shown in the FIGURE.
- the thickness of the applied layer may be, e.g. 200 nm or less, 100 nm or less, or 50 nm or less, in selected embodiments.
- a mediator such as ferricyanide, as known in the art, is co-deposited along with the PPy and GOx.
- This system allows electrochemical measurement of the analyte to be carried out at a voltage of about 0.2-0.4V. A somewhat higher voltage (e.g. 0.7 V), which can lead to interference from other molecules in the interstitial fluid, would typically be required without the mediator.
- Other electron-accepting mediators known in the art for use with GOx include ferrocene derivatives, conducting organic salts such as tetrathiafulvalen-tetracycloquinodimethane (TTF-TCNQ), quinone compounds, phenothiazine compounds, and phenoxazine compounds.
- the multilayer structure of the device containing the capillary channels can be fabricated by known deposition and etching methods.
- the sensing material 22 is, in one embodiment, applied by electrodeposition to one of the exposed edges of the gold electrode within the formed capillary channel 20 , as noted above.
- two noncontiguous edges of electrode are present within the microchannel, to allow for electrochemical detection. These edges could be visualized as two distinct semicircles within the inner surface of the channel, one of which is treated with the sensing material.
- a voltage is applied to the microheater sufficient to ablate the stratum corneum of the underlying skin, e.g. a voltage of about 3 V, typically for about 30 msec.
- This ablation (which typically produces a temperature of about 130° C.) allows interstitial fluid to enter the capillary channel, where it rises via capillary action and hydrostatic pressure and contacts the sensing material (e.g. PPy/GOx) within the capillary.
- a second voltage typically 0.2-0.4 V, is then applied between the two above-described edge portions of the electrode layer), and the level of analyte (e.g. glucose) contacting the sensing material is electronically detected, preferably amperometrically detected, in accordance with known methods.
- analyte e.g. glucose
- the device design presents various advantages, including the following.
- the sensor electrode pair including the metal (e.g. gold) electrode and PPy/GOx-treated electrode (i.e. the two edge regions described above, one treated with sensor material), are located within the microcapillary channel and thus separated spatially from the microheater. This configuration avoids possible heat degradation of the enzyme.
- structural layer 14 is preferably formed of a heat-insulting material, such as a glass or ceramic material.
- the detection of glucose is typically realized using chronoamperometry (measurement of current generated versus time for a voltage step). Ideally, every glucose molecule reaching the GOx sensing electrode should immediately release its electrons to produce the measured current. To achieve this condition, the electrode should have a low surface area to sample volume ratio, to ensure that glucose is not depleted in the vicinity of the sensing electrode during analysis. Accordingly, the sensing electrode is fabricated to be extremely small; i.e. essentially the width of the metal electrode layer 16 , as shown in the FIGURE. Preferred thicknesses (measured in the direction perpendicular to the channel length) of the applied sensor layer 22 may be, e.g.
- Diffusion times i.e. the time for glucose molecules to reach the GOx enzyme are reduced for similar reasons.
- the thickness of a metal layer applied via conventional metal deposition methods can be precisely controlled, as compared to control of lateral dimensions of the planar surface area. Accordingly, high consistency in the effective sensor area (which is, again, the width dimension of the metal electrode layer 16 ), as well as roughness of the electrode layer, is achieved, giving high consistency between one sensor element and another, within a single device or between different devices.
- the gold thickness can be easily reproduced with very little sidewall imperfections/roughness, and the exposed region (at the capillary wall) becomes the sensor electrode area.
- glass/ceramic/polymeric substrate layers are exemplified, other materials, such as paper or other cellulose substrates, electrospun fibers, or other polymers, could also be used for the non-metal layers ( 12 , 14 , 18 ) in the device.
- surfaces contacting the skin such as the lower surface of layer 12
- Methods of treating materials such as paper to render selected portions hydrophobic and/or non-absorbent are known in the art; see, e.g. Martinez, et al., Anal. Chem. 2010, 82, 3-10.
- the surface of structural layer 12 contacting the interior of the microchannel should be non-absorbent but should not repel water, so that sample fluid travels efficiently to the sensing area without volume loss.
- Integrated circuitry including radio frequency (RF) communication capability, may be included peripheral to the device in order to transmit data readings to a remote location.
- this transmission may employ Bluetooth devices, or it may be facilitated as part of a home area network (HAN) in a first instance, e.g., using protocols such as those described as part of the Zigbee standards.
- the data readings may be further transmitted outside of the HAN in accordance with a home health or telehealth communications system using existing wide area networks (WANs) such as the Internet.
- WANs wide area networks
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Optics & Photonics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
- This application is a continuation of application Ser. No. 13/834,199 filed Mar. 15, 2013 and titled “Microfluidic Systems For Electrochemical Transdermal Analyte Sensing Using a Capillary-Located Electrode,” which is incorporated herein by reference in its entirety.
- The present embodiments relate generally to non-invasive or minimally invasive transdermal measurement systems. More specifically, the embodiments relate to microfluidic transdermal glucose measurement systems in which a thin electrode is contained within a fluid-transmitted capillary, and processes for their production and use.
- Minimally invasive transdermal systems are described in, for example, co-owned U.S. Pat. Nos. 6,887,202 and 7,931,592, both entitled “Systems and Methods for Monitoring Health and Delivering Drugs Transdermally,” as well as co-owned U.S. application Ser. No. 13/459,392, each of which is incorporated herein by reference in its entirety. These systems, like the embodiments described herein, provide for a minimally invasive sampling technique and device suitable for rapid, inexpensive, unobtrusive, and pain-free monitoring of important biomedical markers, such as glucose.
- Existing systems remain open to improvement in various aspects, including consistency in sampling and measurement.
- A sensing device, designed to be used in contact with the skin, is provided. The device contains a plurality of individually controllable sites for electrochemically monitoring an analyte, such as glucose, in interstitial fluid of a user. The device includes:
- a hydrophobic layer, designed to contact the skin; an overlaying first structural layer;
- an overlaying metal electrode layer;
- an overlaying second structural layer;
- for each such detection site, a capillary channel traversing these layers, thus providing an opening adjacent the skin;
- wherein said metal electrode layer is discontinuous at the circumference of said capillary channel, such that two non-contiguous edge portions of electrode are present within the circumference of said channel;
- applied to one such edge portion of the metal electrode layer, such that it is exposed to the interior of said capillary channel, a sensing layer effective to measure said analyte; and
- surrounding the lower end of said capillary channel, adjacent said hydrophobic layer, an electronic element (microheater) effective to produce heat when a sufficient voltage is applied thereto.
- Also provided are electrical conduits and contacts such that a voltage can be applied to the microheater, and an additional voltage can be applied between the two edge portions of the electrode layer, and an electrochemical response from the sensing material/electrode layer, indicative of the concentration of analyte in the sample fluid, can be detected.
- In selected embodiments, the hydrophobic layer is hydrophobic silicone. The first structural layer may be a glass or ceramic-like material. The metal electrode layer is preferably gold or platinum, and the sensing layer, for use in detecting glucose, is preferably a conducting polymer, such as polypyrrole (PPy), modified with glucose oxidase (GOx), and preferably further containing an effective amount of a mediator such as ferricyanide. The second structural layer is preferably non-absorbent and/or hydrophobic, and may also be a layer of hydrophobic silicone.
- The diameter of the capillary channel, in one embodiment, is about 50 μm.
- The thickness of the metal electrode layer is generally in the range of 100 nm to 1 micron range, e.g. 100-500 nm, 500-1000 nm, 500-800 nm, 250-750 nm, 300-500 nm, etc. An exemplary thickness is about 500 nm. The structural layers generally have thicknesses such that the overall thickness of the device is about 1 mm or less.
- The thickness of the applied sensing layer, measured in a direction perpendicular to the capillary channel length, may be 200 nm or less, 100 nm or less, or 50 nm or less, in selected embodiments.
- In use, a voltage is applied to the microheater sufficient to ablate the stratum corneum of the underlying skin, e.g. a voltage of about 3 V, typically for about 30 msec. This ablation allows interstitial fluid to enter the capillary channel, where it rises via both capillary action and the body's hydrostatic pressure and contacts the sensing material (e.g. PPy/GOx) within the capillary. A second voltage, typically 0.2-0.4 V, is applied to the electrode layer, i.e. between the two above-described edge portions of the electrode layer, and the level of analyte (e.g. glucose) contacting the sensing material is electrochemically detected, in accordance with known methods.
-
FIG. 1 illustrates an embodiment of a sensing device as disclosed herein. - A section of an exemplary sensing device, designed to be used in contact with the skin, is shown in
FIG. 1 . The device typically contains a plurality of individually controllable sites, of which one is illustrated in the FIGURE, for electrochemically monitoring an analyte, such as glucose, in interstitial fluid of a user. The device, in a preferred embodiment, includes: - a
hydrophobic layer 12, designed to contact the skin; - an overlaying first
structural layer 14; - an overlaying
metal electrode layer 16; - an overlaying second
structural layer 18; - a
capillary channel 20 traversing these layers, thus providing an opening adjacent the skin; - wherein said metal electrode layer is discontinuous at the circumference of said capillary channel, such that two non-contiguous edge portions of electrode are present within the circumference of said channel;
- applied to one such edge portion of the metal electrode layer, such that it is exposed to the interior of said capillary channel, a
sensing layer 22 effective to measure said analyte; and - surrounding the lower end of said capillary channel, adjacent to said hydrophobic layer, an electronic element (microheater) 24, effective to produce heat when a sufficient voltage is applied thereto.
- The diameter of the capillary channel, in one embodiment, is about 50 μm.
- The thickness of the metal electrode layer is generally in the range of 100 nm to 1 micron range, e.g. 100-500 nm, 500-1000 nm, 500-800 nm, 250-750 nm, 300-500 nm, etc. An exemplary thickness is about 500 nm. The thickness of the structural layers is not generally critical (although
layer 12 should be sufficiently thick to insulate sensingmaterial 22 from heat produced by microheater 24), but these may also be in the general range of hundreds of nm, e.g. 100-500 nm, 500-1000 nm, 500-800 nm, 250-750 nm, 300-500 nm, etc. The overall thickness of the device is generally less than 1 mm. - The diameter of the
capillary channel 20, in one embodiment, is about 50 μm. Other diameter ranges, e.g. 10-100 μm, or 25-75 μm, could also be effective. - Also provided, though not shown in the FIGURE, are electrical conduits and contacts such that a voltage can be applied to the microheater, and an additional voltage can be applied to the electrode layer (i.e. between the two above-described edge portions of the electrode layer), and an electrochemical response from the sensing material/electrode layer, indicative of the concentration of analyte in the sample fluid, can be detected. The multiple detection sites within a device are preferably individually controllable; i.e. voltages can be selectively applied to a given detection site or sites by a user of the device.
- In selected embodiments, the
hydrophobic layer 12 is hydrophobic silicone, though any biocompatible/non-irritating hydrophobic material can be used. Thestructural layer 14 may be a glass or ceramic-like material, which provides thermal insulation between themicroheater 24 and sensingmaterial 22, or other structurally stable, nonabsorbent, preferably thermally insulating material. Themetal electrode layer 16 is preferably gold or platinum. - A
sensing layer 22 effective to measure the analyte is present on one of the above-described edge portions of the metal electrode layer, such that it the sensing material is exposed to the interior of the capillary channel. Thesensing layer 22, for use in detecting glucose, is preferably a conducting polymer, such as polypyrrole (PPy), modified with the enzyme glucose oxidase (GOx). - Preferably, in fabrication, the PPy-GOx layer is electrodeposited, in accordance with known methods (see, e.g., Liu et al., Matl. Sci. Eng. C 27(1):47-60 (January 2007); Yamada, et al., Chem. Lett. 26(3):201-202 (1997); Fortier, et al., Biosens. Bioelectronics 5:473-490 (1990)) as an extremely thin layer on an exposed face of the metal electrode, as shown in the FIGURE. Measuring in the direction perpendicular to the capillary length, the thickness of the applied layer may be, e.g. 200 nm or less, 100 nm or less, or 50 nm or less, in selected embodiments.
- In one embodiment, a mediator such as ferricyanide, as known in the art, is co-deposited along with the PPy and GOx. This system allows electrochemical measurement of the analyte to be carried out at a voltage of about 0.2-0.4V. A somewhat higher voltage (e.g. 0.7 V), which can lead to interference from other molecules in the interstitial fluid, would typically be required without the mediator. Other electron-accepting mediators known in the art for use with GOx include ferrocene derivatives, conducting organic salts such as tetrathiafulvalen-tetracycloquinodimethane (TTF-TCNQ), quinone compounds, phenothiazine compounds, and phenoxazine compounds.
- The multilayer structure of the device containing the capillary channels can be fabricated by known deposition and etching methods. The
sensing material 22 is, in one embodiment, applied by electrodeposition to one of the exposed edges of the gold electrode within the formedcapillary channel 20, as noted above. As noted above, two noncontiguous edges of electrode are present within the microchannel, to allow for electrochemical detection. These edges could be visualized as two distinct semicircles within the inner surface of the channel, one of which is treated with the sensing material. - In use, a voltage is applied to the microheater sufficient to ablate the stratum corneum of the underlying skin, e.g. a voltage of about 3 V, typically for about 30 msec. This ablation (which typically produces a temperature of about 130° C.) allows interstitial fluid to enter the capillary channel, where it rises via capillary action and hydrostatic pressure and contacts the sensing material (e.g. PPy/GOx) within the capillary. A second voltage, typically 0.2-0.4 V, is then applied between the two above-described edge portions of the electrode layer), and the level of analyte (e.g. glucose) contacting the sensing material is electronically detected, preferably amperometrically detected, in accordance with known methods.
- The device design presents various advantages, including the following. The sensor electrode pair, including the metal (e.g. gold) electrode and PPy/GOx-treated electrode (i.e. the two edge regions described above, one treated with sensor material), are located within the microcapillary channel and thus separated spatially from the microheater. This configuration avoids possible heat degradation of the enzyme. Further to this aspect,
structural layer 14 is preferably formed of a heat-insulting material, such as a glass or ceramic material. - The detection of glucose is typically realized using chronoamperometry (measurement of current generated versus time for a voltage step). Ideally, every glucose molecule reaching the GOx sensing electrode should immediately release its electrons to produce the measured current. To achieve this condition, the electrode should have a low surface area to sample volume ratio, to ensure that glucose is not depleted in the vicinity of the sensing electrode during analysis. Accordingly, the sensing electrode is fabricated to be extremely small; i.e. essentially the width of the
metal electrode layer 16, as shown in the FIGURE. Preferred thicknesses (measured in the direction perpendicular to the channel length) of the appliedsensor layer 22 may be, e.g. 200 nm or less, 100 nm or less, or 50 nm or less, in selected embodiments, in the 100 nm to 1 micron range, e.g. 500 nm. Diffusion times (i.e. the time for glucose molecules to reach the GOx enzyme) are reduced for similar reasons. - In general, the thickness of a metal layer applied via conventional metal deposition methods, e.g. electrodeposition or vapor deposition, can be precisely controlled, as compared to control of lateral dimensions of the planar surface area. Accordingly, high consistency in the effective sensor area (which is, again, the width dimension of the metal electrode layer 16), as well as roughness of the electrode layer, is achieved, giving high consistency between one sensor element and another, within a single device or between different devices. In fabrication of the multilayer device, the gold thickness can be easily reproduced with very little sidewall imperfections/roughness, and the exposed region (at the capillary wall) becomes the sensor electrode area.
- Although glass/ceramic/polymeric substrate layers are exemplified, other materials, such as paper or other cellulose substrates, electrospun fibers, or other polymers, could also be used for the non-metal layers (12, 14, 18) in the device. However, surfaces contacting the skin, such as the lower surface of
layer 12, should be non-absorbent and preferably hydrophobic in nature, in order to direct fluid flow from the skin into and though thecapillary channel 20 to thesensing material 22. Methods of treating materials such as paper to render selected portions hydrophobic and/or non-absorbent are known in the art; see, e.g. Martinez, et al., Anal. Chem. 2010, 82, 3-10. The surface ofstructural layer 12 contacting the interior of the microchannel should be non-absorbent but should not repel water, so that sample fluid travels efficiently to the sensing area without volume loss. - Integrated circuitry (IC), including radio frequency (RF) communication capability, may be included peripheral to the device in order to transmit data readings to a remote location. By way of example, this transmission may employ Bluetooth devices, or it may be facilitated as part of a home area network (HAN) in a first instance, e.g., using protocols such as those described as part of the Zigbee standards. Further still, the data readings may be further transmitted outside of the HAN in accordance with a home health or telehealth communications system using existing wide area networks (WANs) such as the Internet.
- One skilled in the art recognizes the other areas of application for the devices described herein. While the examples specifically described herein are directed to glucose monitoring, adaptations could be made to ascertain other information from the biomolecules and biomarkers in the interstitial fluid. For example, the individual sites could monitor for infectious disease (microbial, fungal, viral); hazardous compounds; heart or stroke indicators (troponin, C-reactive protein); chemical or biological toxins; cancer markers (PSA, estrogen); drug efficacy and dosing (metabolites): and the like. Such applications of the device as described are considered to be within the scope of the present invention.
Claims (20)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/005,826 US20180289299A1 (en) | 2013-03-15 | 2018-06-12 | Microfluidic Systems For Electrochemical Transdermal Analyte Sensing Using a Capillary-Located Electrode |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/834,199 US10004434B1 (en) | 2013-03-15 | 2013-03-15 | Microfluidic systems for electrochemical transdermal analyte sensing using a capillary-located electrode |
| US16/005,826 US20180289299A1 (en) | 2013-03-15 | 2018-06-12 | Microfluidic Systems For Electrochemical Transdermal Analyte Sensing Using a Capillary-Located Electrode |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/834,199 Continuation US10004434B1 (en) | 2013-03-15 | 2013-03-15 | Microfluidic systems for electrochemical transdermal analyte sensing using a capillary-located electrode |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20180289299A1 true US20180289299A1 (en) | 2018-10-11 |
Family
ID=51580627
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/834,199 Active 2035-02-22 US10004434B1 (en) | 2013-03-15 | 2013-03-15 | Microfluidic systems for electrochemical transdermal analyte sensing using a capillary-located electrode |
| US16/005,826 Abandoned US20180289299A1 (en) | 2013-03-15 | 2018-06-12 | Microfluidic Systems For Electrochemical Transdermal Analyte Sensing Using a Capillary-Located Electrode |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/834,199 Active 2035-02-22 US10004434B1 (en) | 2013-03-15 | 2013-03-15 | Microfluidic systems for electrochemical transdermal analyte sensing using a capillary-located electrode |
Country Status (2)
| Country | Link |
|---|---|
| US (2) | US10004434B1 (en) |
| WO (1) | WO2014149514A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10898116B2 (en) | 2013-03-15 | 2021-01-26 | Cambridge Medical Technologies LLC | Methods of manufacture to optimize performance of transdermal sampling and analysis device |
| US9855554B2 (en) * | 2013-07-22 | 2018-01-02 | President And Fellows Of Harvard College | Microfluidic cartridge assembly |
| WO2017023931A1 (en) * | 2015-08-03 | 2017-02-09 | Georgetown University | Apparatus and method for delivery of antimicrobial during a transdermal sampling and delivery process |
| WO2018080923A1 (en) | 2016-10-28 | 2018-05-03 | Georgetown University | Non-invasive passive interstitial fluid collector |
| WO2018144506A1 (en) | 2017-01-31 | 2018-08-09 | Georgetown University | Harvesting cell-free non-coding rnas (cfncrs) from interstitial fluid for sensitive biomarkers |
| US11633129B2 (en) | 2019-04-05 | 2023-04-25 | Cambridge Medical Technologies LLC | Non-invasive transdermal sampling and analysis device incorporating redox cofactors |
| JP7167824B2 (en) * | 2019-04-08 | 2022-11-09 | 日本電信電話株式会社 | perspiration analyzer |
| US11375931B2 (en) * | 2019-08-08 | 2022-07-05 | Cambridge Medical Technologies LLC | Non-invasive transdermal sampling and analysis device incorporating an electrochemical bioassay |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5885211A (en) * | 1993-11-15 | 1999-03-23 | Spectrix, Inc. | Microporation of human skin for monitoring the concentration of an analyte |
| US20070027383A1 (en) * | 2004-07-01 | 2007-02-01 | Peyser Thomas A | Patches, systems, and methods for non-invasive glucose measurement |
| US20120060589A1 (en) * | 2009-04-03 | 2012-03-15 | Nxp B.V. | Sensor device and a method of manufacturing the same |
| US20120150004A1 (en) * | 2010-12-10 | 2012-06-14 | Flexible Medical Systems Llc | Transdermal Sampling and Analysis Device |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4526176A (en) | 1981-12-22 | 1985-07-02 | Frantz Medical Development Ltd. | Long-life biomedical application device, particularly electrode, and method of transferring electrical current |
| US4909256A (en) | 1985-02-11 | 1990-03-20 | The United States Of America, As Represented By The Secretary Of The Army | Transdermal vapor collection method and apparatus |
| US4775361A (en) | 1986-04-10 | 1988-10-04 | The General Hospital Corporation | Controlled removal of human stratum corneum by pulsed laser to enhance percutaneous transport |
| US4821733A (en) | 1987-08-18 | 1989-04-18 | Dermal Systems International | Transdermal detection system |
| ES2007583T3 (en) | 1987-09-04 | 1993-09-16 | Willi Moller Ag | SELECTIVE PART OF IONS DEVICES TO DETERMINE ION CONCENTRATIONS AND PROCEDURE FOR THE PRODUCTION OF POLYMER MATERIALS PRESENTED BY HYDROPHILIC GROUPS. |
| US5362307A (en) | 1989-01-24 | 1994-11-08 | The Regents Of The University Of California | Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance |
| US5330527A (en) | 1988-03-25 | 1994-07-19 | Lec Tec Corporation | Multipurpose medical electrode |
| US5078134A (en) | 1988-04-25 | 1992-01-07 | Lifecor, Inc. | Portable device for sensing cardiac function and automatically delivering electrical therapy |
| US5203327A (en) | 1988-09-08 | 1993-04-20 | Sudor Partners | Method and apparatus for determination of chemical species in body fluid |
| DE3831141A1 (en) | 1988-09-13 | 1990-03-22 | Zeiss Carl Fa | METHOD AND DEVICE FOR MICROSURGERY ON EYE BY LASER RADIATION |
| US5176881A (en) | 1989-08-11 | 1993-01-05 | The University Of Tennessee Research Corporation | Fiber optic-based regenerable biosensor |
| NL9002764A (en) * | 1990-12-14 | 1992-07-01 | Tno | ELECTRODE, FITTED WITH A POLYMER COATING WITH A REDOX ENZYM BOND TO IT. |
| JPH05172815A (en) | 1991-12-26 | 1993-07-13 | Hitachi Ltd | Immunity analyzing method and analyzing device therefor |
| US5380272A (en) | 1993-01-28 | 1995-01-10 | Scientific Innovations Ltd. | Transcutaneous drug delivery applicator |
| US6251100B1 (en) | 1993-09-24 | 2001-06-26 | Transmedica International, Inc. | Laser assisted topical anesthetic permeation |
| US5458140A (en) | 1993-11-15 | 1995-10-17 | Non-Invasive Monitoring Company (Nimco) | Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers |
| US5591139A (en) | 1994-06-06 | 1997-01-07 | The Regents Of The University Of California | IC-processed microneedles |
| JP2718408B2 (en) | 1995-09-20 | 1998-02-25 | 日本電気株式会社 | Leachate suction device |
| US5801057A (en) | 1996-03-22 | 1998-09-01 | Smart; Wilson H. | Microsampling device and method of construction |
| WO1997042888A1 (en) | 1996-05-17 | 1997-11-20 | Mercury Diagnostics Inc. | Blood and interstitial fluid sampling device |
| US6120460A (en) | 1996-09-04 | 2000-09-19 | Abreu; Marcio Marc | Method and apparatus for signal acquisition, processing and transmission for evaluation of bodily functions |
| US7220550B2 (en) | 1997-05-14 | 2007-05-22 | Keensense, Inc. | Molecular wire injection sensors |
| US6124597A (en) | 1997-07-07 | 2000-09-26 | Cedars-Sinai Medical Center | Method and devices for laser induced fluorescence attenuation spectroscopy |
| AU2898699A (en) | 1998-03-06 | 1999-09-20 | Altea Technologies, Inc. | Photothermal structure for biomedical applications, and method therefor |
| CA2311487C (en) | 1998-05-13 | 2004-02-10 | Cygnus, Inc. | Signal processing for measurement of physiological analytes |
| ATE220936T1 (en) | 1998-05-13 | 2002-08-15 | Cygnus Therapeutic Systems | COLLECTION DEVICES FOR TRANSDERMAL SAMPLING SYSTEMS |
| US7344499B1 (en) | 1998-06-10 | 2008-03-18 | Georgia Tech Research Corporation | Microneedle device for extraction and sensing of bodily fluids |
| JP2004510453A (en) | 1998-07-21 | 2004-04-08 | スペクトルクス,インコーポレイティド | Systems and methods for continuous analyte monitoring |
| EP1112021A1 (en) | 1998-09-10 | 2001-07-04 | Spectrx, Inc. | Attribute compensation for analyte detection and/or continuous monitoring |
| US6464687B1 (en) | 1999-03-09 | 2002-10-15 | Ball Semiconductor, Inc. | Implantable drug delivery system |
| CA2688795C (en) | 2000-06-01 | 2014-07-08 | Science Application International Corporation | Systems and methods for monitoring health and delivering drugs transdermally |
| US6730212B1 (en) | 2000-10-03 | 2004-05-04 | Hrl Laboratories, Llc | Sensor for chemical and biological materials |
| US7655477B1 (en) | 2003-02-26 | 2010-02-02 | Science Applications International Corporation | System and method for the separation of analytes |
| US7888509B2 (en) | 2003-10-30 | 2011-02-15 | Georgetown University | Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors |
| US8333874B2 (en) | 2005-12-09 | 2012-12-18 | Flexible Medical Systems, Llc | Flexible apparatus and method for monitoring and delivery |
| WO2009025698A1 (en) | 2007-08-17 | 2009-02-26 | Vivomedical, Inc. | Devices, systems, and methods for the measurement of analytes |
| EP2232249A4 (en) | 2007-12-13 | 2014-04-16 | Univ Monash | BIOCAPTOR SYSTEM ELECTROCHEMICAL NANOCOMPOSITE |
| CN102016596B (en) | 2008-03-27 | 2014-09-17 | 哈佛学院院长等 | Paper-Based Microfluidic Systems |
-
2013
- 2013-03-15 US US13/834,199 patent/US10004434B1/en active Active
-
2014
- 2014-02-28 WO PCT/US2014/019183 patent/WO2014149514A1/en not_active Ceased
-
2018
- 2018-06-12 US US16/005,826 patent/US20180289299A1/en not_active Abandoned
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5885211A (en) * | 1993-11-15 | 1999-03-23 | Spectrix, Inc. | Microporation of human skin for monitoring the concentration of an analyte |
| US20070027383A1 (en) * | 2004-07-01 | 2007-02-01 | Peyser Thomas A | Patches, systems, and methods for non-invasive glucose measurement |
| US20120060589A1 (en) * | 2009-04-03 | 2012-03-15 | Nxp B.V. | Sensor device and a method of manufacturing the same |
| US20120150004A1 (en) * | 2010-12-10 | 2012-06-14 | Flexible Medical Systems Llc | Transdermal Sampling and Analysis Device |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014149514A1 (en) | 2014-09-25 |
| US10004434B1 (en) | 2018-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20180289299A1 (en) | Microfluidic Systems For Electrochemical Transdermal Analyte Sensing Using a Capillary-Located Electrode | |
| US20220386904A1 (en) | Transdermal sensing of analytes in interstitial fluid and associated data transmission systems | |
| JP7135218B2 (en) | Analyte sensor and detection method for detecting creatinine | |
| US6793632B2 (en) | Percutaneous biological fluid constituent sampling and measurement devices and methods | |
| AU784699B2 (en) | Percutaneous biological fluid sampling and analyte measurement devices and methods | |
| AU784526B2 (en) | Biological fluid sampling and analyte measurement devices and methods | |
| JP4879459B2 (en) | Electrochemical biosensor strip for analysis of liquid samples | |
| ES2326286T3 (en) | SANDWICH TYPE SENSOR TO DETERMINE THE CONCENTRATION OF AN ANALYTE. | |
| CN104918551B (en) | Sensor module and method of using the sensor module | |
| US20210361204A1 (en) | Electrochemical sensors and methods for making electrochemical sensors using advanced printing technology | |
| KR20020094899A (en) | Percutaneous biological fluid sampling and analyte measurement devices and methods | |
| CN110049711A (en) | Accurate sweat enzyme sensing analysis | |
| CZ20022021A3 (en) | Device and method for taking a sample and measuring a component of a biological liquid | |
| CA2428365A1 (en) | Physiological sample collection devices and methods of using the same | |
| US20220079480A1 (en) | Continuous ex-vivo affinity-based sensing of interstitial fluid | |
| Yuen et al. | Electrolyte-sensing transistor decals enabled by ultrathin microbial nanocellulose | |
| WO2019186129A1 (en) | Microneedle platform for sensing and delivery | |
| TW202222255A (en) | Analyte sensor and a method for producing an analyte sensor | |
| WO2014149161A2 (en) | Microfluidic systems for electrochemical transdermal glucose sensing using a paper-based or other wicking substrate | |
| Tokranova et al. | Highly sensitive fentanyl detection based on nanoporous electrochemical immunosensors | |
| TWI571238B (en) | Noninvasive metabolites sensor | |
| KR20210088979A (en) | Sensing device | |
| WO2022067026A1 (en) | Small volume aptamer sensing without solution impedance or analyte depletion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: GEORGETOWN UNIVERSITY, DISTRICT OF COLUMBIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PARANJAPE, MAKARAND;REEL/FRAME:046052/0548 Effective date: 20130412 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |